Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate Measurements in the Intensive Care Unit

This study has been completed.
Sponsor:
Information provided by:
Olive View-UCLA Education & Research Institute
ClinicalTrials.gov Identifier:
NCT01408251
First received: August 1, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted
  Purpose

The purpose of this study is to see if blood obtained from a vein (smaller blood vessel) can be used instead of blood obtained from an artery (larger blood vessel).


Condition
Acid-base Analysis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit

Further study details as provided by Olive View-UCLA Education & Research Institute:

Enrollment: 40
Study Start Date: January 2008
Study Completion Date: July 2008
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Intensive Care Unit patients requiring both an arterial line and central venous line as part of their clinical care

Criteria

Inclusion Criteria:

  • Patients admitted to the ICU and requiring both an arterial line and central venous line as prt of their clinical care

Exclusion Criteria:

  • Patient did not desire to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01408251

Sponsors and Collaborators
Olive View-UCLA Education & Research Institute
Investigators
Principal Investigator: Richard M Treger, M.D. VA Greater Los Angeles Healthcare System
  More Information

No publications provided

Responsible Party: Richard Treger/Principal Investigator, VA Greater Los Angeles Healthcare System
ClinicalTrials.gov Identifier: NCT01408251     History of Changes
Other Study ID Numbers: 193070
Study First Received: August 1, 2011
Last Updated: August 1, 2011
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 20, 2014